1538 studies found for:    bind
Show Display Options
Rank Status Study
1 Active, not recruiting A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: CRPC;   Prostate Cancer
Intervention: Drug: BIND-014
2 Active, not recruiting A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Conditions: Metastatic Cancer;   Cancer;   Solid Tumors
Intervention: Drug: BIND-014
3 Recruiting A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: BIND-014
4 Active, not recruiting Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: HEAD & NECK Cancer
Intervention: Other: Cetuximab, IMRT, Albumin-bound paclitaxel (Abraxane®)
5 Not yet recruiting Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries
Conditions: Demonstrate BIND II Score of >=5, is Valid for Detecting Moderate to Severe ABE in Neonates <14 Days Old.;   Demonstrate Community-BIND Instrument, a Modified BIND II, is a Valid and Reliable Tool for Detecting ABE.;   Demonstrate That Community-BIND Can be Used for Acquiring Population-based Prevalence of ABE in the Community.
Intervention:
6 Recruiting Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer
Condition: Uterine Cervical Cancer
Intervention: Drug: albumin-bound paclitaxel plus nedaplatin
7 Recruiting Plasma Protein Binding Characteristics of Voriconazole
Condition: Focus of the Study:Protein Binding Characteristics of Voriconazole.
Intervention: Other: Blood sampling
8 Not yet recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus
Condition: Squamous Cell Carcinoma of Esophagus
Intervention: Drug: nanoparticle albumin-bound paclitaxel
9 Completed Diagnostic Value of Heart-Fatty Acid Binding Protein and Ischemia Modified Albumin as Biochemical Markers on Non ST Segment Elevation Acute Coronary Syndrome at the Emergency Room.
Condition: Acute Coronary Syndrome
Intervention: Other: Measure of Initial heart fatty acid binding protein and ischemia modified albumin
10 Recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung
Condition: Non-small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel/carboplatin
11 Not yet recruiting Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: nanoparticle albumin-bound paclitaxel
12 Recruiting Canadian Biomarker Integration Network for Depression Study
Condition: Major Depressive Disorder
Interventions: Drug: escitalopram;   Drug: aripiprazole
13 Completed TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: colloidal gold-bound tumor necrosis factor;   Other: pharmacological study
14 Completed A Human Proof of Concept Study for [11C]-RO5011232 as Radiotracer and Study of the Binding of RO4917523 to Human mGlu5 Brain Receptor at Steady-State in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: RO4917523;   Drug: RO5011232
15 Recruiting The Value of HBA in the Evaluation of Idiopathic Infertility
Condition: Infertility
Intervention: Other: HBA binding assay
16 Unknown  Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
Condition: Myeloid Leukemia
Intervention:
17 Unknown  Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis
Condition: Uremia
Intervention: Procedure: mFPSA treatment
18 Recruiting Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Biological: E39 peptide vaccine;   Biological: E39 vaccine then J65 vaccine;   Biological: J65 vaccine then E39 vaccine
19 Completed Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
Conditions: Hyperlipidemia;   Atherosclerosis
Intervention: Drug: Temporary discontinuation of statin therapy
20 Terminated Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
Condition: Depression
Intervention: Procedure: 123-I MZINT injection and SPECT imaging

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years